Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram

Carey, Paul D.; Warwick, James; Niehaus, Dana J. H.; Van der Linden, Geoffrey; Van Heerden, Barend B.; Harvey, Brian H.; Seedat, Soraya; Stein, Dan J.
January 2004
BMC Psychiatry;2004, Vol. 4, p30
Academic Journal
Background: Several studies have now examined the effects of selective serotonin reuptake inhibitor (SSRI) treatment on brain function in a variety of anxiety disorders including obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), and social anxiety disorder (social phobia) (SAD). Regional changes in cerebral perfusion following SSRI treatment have been shown for all three disorders. The orbitofrontal cortex (OFC) (OCD), caudate (OCD), medial pre-frontal/cingulate (OCD, SAD, PTSD), temporal (OCD, SAD, PTSD) and, thalamic regions (OCD, SAD) are some of those implicated. Some data also suggests that higher perfusion pre-treatment in the anterior cingulate (PTSD), OFC, caudate (OCD) and antero-lateral temporal region (SAD) predicts subsequent treatment response. This paper further examines the notion of overlap in the neurocircuitry of treatment and indeed treatment response across anxiety disorders with SSRI treatment. Methods: Single photon emission computed tomography (SPECT) using Tc-99 m HMPAO to assess brain perfusion was performed on subjects with OCD, PTSD, and SAD before and after 8 weeks (SAD) and 12 weeks (OCD and PTSD) treatment with the SSRI citalopram. Statistical parametric mapping (SPM) was used to compare scans (pre- vs post-medication, and responders vs non-responders) in the combined group of subjects. Results: Citalopram treatment resulted in significant deactivation (p = 0.001) for the entire group in the superior (t = 4.78) and anterior (t = 4.04) cingulate, right thalamus (t = 4.66) and left hippocampus (t = 3.96). Deactivation (p = 0.001) within the left precentral (t = 4.26), right mid-frontal (t = 4.03), right inferior frontal (t = 3.99), left prefrontal (3.81) and right precuneus (t= 3.85) was more marked in treatment responders. No pattern of baseline activation distinguished responders from non-responders to subsequent pharmacotherapy. Conclusions: Although each of the anxiety disorders may be mediated by different neurocircuits, there is some overlap in the functional neuro-anatomy of their response to SSRI treatment. The current data are consistent with previous work demonstrating the importance of limbic circuits in this spectrum of disorders. These play a crucial role in cognitive-affective processing, are innervated by serotonergic neurons, and changes in their activity during serotonergic pharmacotherapy seem crucial.


Related Articles

  • Pharmacotherapy response and regional cerebral blood flow characteristics in patients with obsessive-compulsive disorder. Sheng-lin Wen; Mu-hua Cheng; Min-feng Cheng; Ji-hui Yue; Hong Wang // Behavioral & Brain Functions;2013, Vol. 9 Issue 1, p1 

    Objective: To analyze the correlation between the pharmacotherapy response and the characteristics of the pre-treatment regional cerebral blood flow (rCBF) in patients with obsessive-compulsive disorder (OCD). Methods: Single-photon emission-computed tomography (SPECT) was used to determine the...

  • Differences in cerebral perfusion according to phenotypes of essential tremor: brain perfusion SPECT study using SPM analysis. Song, In-Uk; Park, Jeong-Wook; Chung, Sung-Woo; Chung, Yong-An // Neurological Sciences;May2014, Vol. 35 Issue 5, p767 

    Essential tremor (ET) is one of the most common movement disorders. However, few studies regarding the differences of pathophysiology according to phenotypes of ET have been reported. We investigated whether a functional difference occurs between ET with only a limb tremor (L-ET) and ET with...

  • Damage Control for the Young. Fawcett, Jan // Psychiatric Annals;Mar2013, Vol. 43 Issue 3, p94 

    An introduction to the March 2013 issue of "Psychiatric Annals," is presented in which the editor various reports published within the issue which include a review on the use of selective serotonin reuptake inhibitor (SSRI) medications for anxiety disorders and depression in children and...

  • Antidepressants are the main options for the long-term pharmacological treatment of generalized anxiety disorder.  // Drugs & Therapy Perspectives;Jan2010, Vol. 26 Issue 1, p12 

    Generalized anxiety disorder (GAD) is a chronic condition that is common in both adults and children. Cognitivebehavioural therapy and/or pharmacological treatment with selective serotonin reuptake inhibitors or serotonin-noradrenaline reuptake inhibitors are first-line options in the long-term...

  • Anxiety disorders. Perry, Amanda; Russell, David // Pulse;Jun2015, p72 

    The article has Dr. Amanda Perry answering questions related to panic attacks and the role of herbal and homeopathic remedies in treating anxiety disorders, and a table showing the best lines of treatment like Selective Serotonin Reuptake Inhibitor (SSRI) is also provided.

  • Effect of Fluoxetine on Brain Oxidative Stress, Neuronal Damage and Behavioural Induced in the Olfactory Bulbectomy Model of Depression. Tunez, Isaac; Medina, Francisco J.; Jimena, Ignacio; Mu�oz, Mar�a del C.; Pe�a, Jos�; Tasset, Inmaculada; Montilla, Pedro // Letters in Drug Design & Discovery;May2007, Vol. 4 Issue 4, p305 

    We demonstrate that olfactory bulbectomy produced oxidative and cell damage together with behavioural changes. This situation was reversed by fluoxetine administration. The data suggest that oxidative stress may represent common pathophysiological mechanisms in this experimental model, as well...

  • Interaction between BDNF and Serotonin: Role in Mood Disorders. Martinowich, Keri; Bai Lu // Neuropsychopharmacology;Jan2008, Vol. 33 Issue 1, p73 

    Brain-derived neurotrophic factor (BDNF) and serotonin (5-hydroxytryptamine, 5-HT) are two seemingly distinct signaling systems that play regulatory roles in many neuronal functions including survival, neurogenesis, and synaptic plasticity. A common feature of the two systems is their ability to...

  • REM sleep behaviour disorder: a window on the sleeping brain. Mahowald, Mark W.; Schenck, Carlos H. // Brain: A Journal of Neurology;May2015, Vol. 138 Issue 5, p1131 

    No abstract available.

  • New and Recent Drugs for Anxiety Disorders. Choy, Yujuan; Schneier, Franklin R. // Primary Psychiatry;Dec2008, Vol. 15 Issue 12, p50 

    Serotonin reuptake inhibitors and benzodiazepines are currently the mainstays of treatment for anxiety disorders. Recent advances in novel anxiolytic agents with mechanisms of action at the γ-aminobutyric acid-ergic, serotonergic, and glutamatergic systems have garnered a great deal of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics